Delos Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.5K Buy
+253
New +$29.6K 0.02% 143
2025
Q1
Sell
-400
Closed -$39.8K 137
2024
Q4
$39.8K Hold
400
0.03% 81
2024
Q3
$45.4K Sell
400
-36
-8% -$4.28K 0.04% 83
2024
Q2
$54K Hold
436
0.05% 77
2024
Q1
$57.5K Buy
436
+36
+9% +$4.44K 0.06% 67
2023
Q4
$43.6K Sell
400
-20
-5% -$2.08K 0.06% 64
2023
Q3
$45.8K Hold
420
0.06% 73
2023
Q2
$48.5K Hold
420
0.06% 66
2023
Q1
$44.7K Hold
420
0.06% 66
2022
Q4
$46.6K Hold
420
0.07% 61
2022
Q3
$36K Hold
420
0.04% 63
2022
Q2
$38K Hold
420
0.04% 66
2022
Q1
$34K Sell
420
-186
-31% -$14.7K 0.03% 85
2021
Q4
$46K Buy
+606
New +$48.3K 0.04% 81

Other funds holding MRK

Delos Wealth Advisors's MRK Position: Q2 2026 in Review

Delos Wealth Advisors opened a new position in Merck (MRK) in Q2 2026: 253 shares worth $32.5K. The stake represents 0.02% of the portfolio and ranks #143 among its holdings. This is a return to the name: Delos Wealth Advisors previously reported a position in MRK as recently as Q4 2024.

Delos Wealth Advisors first reported a position in MRK in Q4 2021 and has held it in 14 quarters since. The position peaked at $57.5K in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Delos Wealth Advisors held 253 shares of Merck worth $32.5K as of Q2 2026.
  • Merck was a new Delos Wealth Advisors position in Q2 2026.
  • Merck made up 0.02% of Delos Wealth Advisors's portfolio in Q2 2026, its #143 holding.
  • Delos Wealth Advisors first reported a position in Merck in Q4 2021 and has held it in 14 quarters since.
  • Delos Wealth Advisors's Merck position peaked at $57.5K in Q1 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.